Technology
Health
Pharmaceutical

Arcus Biosciences

$8.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (0.95%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours

Why Robinhood?

You can buy or sell RCUS and other stocks, options, ETFs, and crypto commission-free!

About RCUS

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The firm compete in the segments of the pharmaceutical, biotechnology and other related markets that develop immunotherapies for the treatment of cancer. Read More The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Employees
108
Headquarters
Hayward, California
Founded
2015
Market Cap
376.32M
Price-Earnings Ratio
Dividend Yield
Average Volume
111.17K
High Today
$8.59
Low Today
$8.40
Open Price
$8.40
Volume
47.82K
52 Week High
$16.06
52 Week Low
$7.15

Collections

Technology
Health
Pharmaceutical
Biotechnology
Cancer Prevention
2018 IPO
US
North America

RCUS Earnings

-$1.37
-$1.00
-$0.62
-$0.25
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 5, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.